Mary Lou Clements-Mann
#27,854
Most Influential Person Now
American biologist
Mary Lou Clements-Mann's AcademicInfluence.com Rankings
Mary Lou Clements-Mannbiology Degrees
Biology
#3447
World Rank
#5273
Historical Rank
#1394
USA Rank
Molecular Biology
#578
World Rank
#592
Historical Rank
#157
USA Rank
Download Badge
Biology
Mary Lou Clements-Mann's Degrees
- PhD Biology Stanford University
- Bachelors Biology University of California, Berkeley
Similar Degrees You Can Earn
Why Is Mary Lou Clements-Mann Influential?
(Suggest an Edit or Addition)According to Wikipedia, Mary Lou Clements-Mann was the founder and first Director of the Center for Immunization Research at the Johns Hopkins Bloomberg School of Public Health and is well known for her work in the areas of HIV and influenza vaccine research.
Mary Lou Clements-Mann's Published Works
Published Works
- Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. (1997) (424)
- Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children. (1997) (203)
- Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group. (1998) (201)
- A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers. (1999) (180)
- A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant. (1999) (106)
- Safety profile of phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation Group. (1997) (81)
- Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults. (2000) (79)
- Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants. (1999) (71)
- Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with rgp120. (2001) (69)
- Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants. (2001) (62)
- Lessons for AIDS vaccine development from non-AIDS vaccines. (1998) (36)
- Immunogenicity of two doses of yeast recombinant hepatitis B vaccine in healthy older adults. (1997) (26)
- Neutralization of syncytium-inducing primary isolates by sera from human immunodeficiency virus (HIV)-uninfected recipients of candidate HIV vaccines. (1998) (18)
- Clinical evaluation of a single oral dose of human‐bovine (UK) reassortant rotavirus vaccines Wa x UK (P1A[8],G6) and Wa x (DS‐1 x UK) (P1A[8],G2) (2002) (16)
- FACTORS CONFERRING PROTECTION AGAINST ROTAVIRUS INFECTION IN CHILDREN (1999) (0)
- SAFETY AND IMMUNOGENICITY OF LIVE ATTENUATED HUMAN-BOVINE (UK) REASSORTANT ROTAVIRUS VACCINE WITH VP7-SPECIFICITY FOR SEROTYPE 4 (G4) IN CHILDREN AND YOUNG INFANTS (1999) (0)
This paper list is powered by the following services:
Other Resources About Mary Lou Clements-Mann
What Schools Are Affiliated With Mary Lou Clements-Mann?
Mary Lou Clements-Mann is affiliated with the following schools: